XLH-48597-46482 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-19
Dose 1 — Pfizer-BioNTech
2020-12-21
Registered in v-safe
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness, Diarrhea

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2020-12-24
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2020-12-26
Health check-in — day 7, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-02
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-09
Dose 2 — Pfizer-BioNTech
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work

Adult check-in
2021-01-15
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-18
Health check-in — day 7, dose 2
Feeling: Good · Headache, Joint pains, Muscle or body aches

Adult check-in
2021-01-23
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-01
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-06
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-13
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-22
Survey response — day 42, dose 2
MedDRA: Diarrhoea, Fatigue, Headache, Nausea — Feeling: Fair · Be unable to do your normal daily activities

Free text: Headache, fatigue, diarrhea, nausea

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-10
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-18
Dose 3 — Pfizer-BioNTech
2022-10-25
Dose 4 — Pfizer-BioNTech
2022-11-02
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-11-11
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-11-15
Health check-in — day 21, dose 4
Feeling: Fair

Adult check-in
2022-11-23
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-12-02
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-12-06
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2023-01-25
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-19	Pfizer-BioNTech
2	2021-01-09	Pfizer-BioNTech
3	2021-10-18	Pfizer-BioNTech	No
4	2022-10-25	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2020-12-24	priority 2/3
2021-01-15	priority 2/3

Free text

Release 4 — day 42, dose 2

2021-02-22

Symptoms: Headache, fatigue, diarrhea, nausea

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Diarrhoea	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Nausea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release